Skip to main content
Obesity PreventionNutrition and dietExercise and fitnessGeneticsWeight lossDiagnostics and screeningBehavioralBehavioral

What this study is

This study aims to explore the association between Melanocortin-4 Receptor (MC4R) polymorphisms, eating habits, and social determinants of health in a heterogeneous adult population in Georgia, USA.

What's being tested

  • Diet and exercise

    Intervention · BEHAVIORAL

    Diet intervention: Participants will be randomly divided into a control group (n=50) and a training group (n=50) using the simplest method of assigning participants to different treatment groups: a coin toss. They will be surveyed using the modified DHII questionnaire to assess their caloric intake. The baseline calorie intake will be evaluated during the first visit. Participants will be instructed to reduce their portion sizes by half of what they typically consume. The commitment of participants will be for 8 weeks. Exercise intervention: In the first visit, subjects will be familiarized with exercise on a bicycle ergometer to eliminate the novel effects of a new experience. The subjects in the training group will then come to our laboratory to participate in an 8-week exercise program; the control group will not undergo training during this experimental period. The training group will train on a bicycle ergometer for 30 minutes, 3 days a week, for 8 weeks.

  • Lifestyle Intervention

    Intervention · BEHAVIORAL

    8-week personalized diet using a personalized low-calorie diet based on the caloric intake baseline using modified Diet History Questionnaire II (DHQ II)

  • Exercise

    Intervention · BEHAVIORAL

    8-week personalized physical activity- subjects will be doing 30-minute exercise three times a week using a bicycle ergometer

Study details

Official title
Assessing Obesity Related Risk Factors in Burke, Columbia, Richmond (BCR) Adult Population: A Genetic and Behavioral Study
Sponsor
Augusta University
Conditions
Obesity Prevention
Enrolling
100 people
Starts
2026-01-01
Est. completion
2026-12-01
Design
Open-label, single group
Record
View on ClinicalTrials.gov ↗